Clarity first
Every screen is stripped back to what matters. Just the inputs, the references, and the result that supports a choice.
Independent clinical tools
Appcardio is a quiet layer of technology for busy clinical days. It helps with calculation and structure, so cardiologists can focus on judgment and patients.
No account. No advertisement. No aggressive tracking. Only tools that support careful decisions at the point of care.
The platform is built with a small set of principles. Each decision about design and engineering follows them.
Every screen is stripped back to what matters. Just the inputs, the references, and the result that supports a choice.
Formulas and thresholds follow international cardiology guidance. Content is curated from major societies and peer reviewed work.
Tools are free to use for clinicians everywhere. No registration wall and no premium tier that hides essential functions.
Clinical choices shape real lives. That is why the tools that support those choices must remain free from commercial influence.
Appcardio is funded and developed independently. There is no advertising network and no sponsored content. The platform does not sell data or attention.
This independence creates room for something simple. A place where guidelines and reasoning can stand without noise, agenda, or hidden trade.
Founder and CEO
Monza is a cardiology resident with clinical involvement in ward care, echocardiography, and daily decision-making in cardiovascular practice.
Appcardio originated as a set of personal calculation tools used during training, gradually developing into a platform as the need for structured and reliable decision support became more apparent.
The objective remains straightforward. To provide practical clinical tools that support reasoning, maintain accuracy, and focus on relevance without unnecessary complexity.
A quiet timeline of small experiments, refactors, and conversations with colleagues.
Simple scores live in notebooks and personal spreadsheets. Small functions help during call but exist only on a single device.
Core calculators move into a clean web interface. Colleagues begin to use the tools during rounds and echo sessions.
New sections appear for echocardiography, risk scores, and heart failure. The focus stays on structure and reliability.
Appcardio is maintained as an independent platform under PT Appcardio Platform Indonesia. Development continues with careful, incremental releases.
Future work explores guideline aware workflows and safer automation. Always with transparency and clinical control at the centre.
Appcardio will keep changing, slowly and intentionally. New tools will arrive only when they are ready and grounded in evidence.
Thank you for using the platform in your day to day practice. Every visit, email, and suggestion helps shape what Appcardio becomes next.